San Marino, CA, United States of America

Cary A Presant

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 353(Granted Patents)


Company Filing History:


Years Active: 1991-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cary A. Presant

Introduction

Cary A. Presant is a notable inventor based in San Marino, California, recognized for his significant contributions to the field of medical technology. With a total of four patents to his name, Presant has focused on developing methods that enhance the delivery of therapeutic agents to targeted locations within the body.

Latest Patents

Among his latest patents is a method of targeting a specific location in the body using phospholipid and cholesterol liposomes that encapsulate an agent. This innovative approach involves administering micellular particles, such as small unilamellar vesicles of less than 2000 Å, to BALB/c mice with induced tumors. The results demonstrated a substantial quantity of the vesicle entrapped, localized in the tumor. Additionally, he developed a method for delivering micellular particles encapsulating chemotherapeutic agents and a marker to tumors for diagnosis and treatment. This method enhances the delivery of micellular particles by introducing an initial group of positively charged micellular particles to block reticuloendothelial cells present in the body.

Career Highlights

Cary A. Presant has worked with prominent companies in the biotechnology sector, including Vestar, Inc. and Gilead Sciences, Inc. His work has significantly impacted the development of targeted therapies, showcasing his expertise in the field.

Collaborations

Throughout his career, Presant has collaborated with notable professionals, including Richard T. Proffitt and Raymond L. Teplitz. These collaborations have contributed to the advancement of his innovative projects and patents.

Conclusion

Cary A. Presant's work exemplifies the intersection of innovation and medical technology. His patents reflect a commitment to improving therapeutic delivery systems, which may lead to enhanced treatment outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…